QQQ   423.32 (-0.59%)
AAPL   166.93 (-0.64%)
MSFT   405.46 (-1.55%)
META   502.30 (+1.65%)
GOOGL   156.26 (+0.51%)
AMZN   179.19 (-1.15%)
TSLA   150.47 (-3.20%)
NVDA   845.58 (+0.62%)
AMD   154.32 (+0.19%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.23 (+0.68%)
F   12.03 (-0.08%)
MU   112.61 (-3.20%)
GE   153.77 (-1.22%)
CGC   8.15 (+25.58%)
DIS   112.95 (+0.01%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.37 (-0.22%)
QQQ   423.32 (-0.59%)
AAPL   166.93 (-0.64%)
MSFT   405.46 (-1.55%)
META   502.30 (+1.65%)
GOOGL   156.26 (+0.51%)
AMZN   179.19 (-1.15%)
TSLA   150.47 (-3.20%)
NVDA   845.58 (+0.62%)
AMD   154.32 (+0.19%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.23 (+0.68%)
F   12.03 (-0.08%)
MU   112.61 (-3.20%)
GE   153.77 (-1.22%)
CGC   8.15 (+25.58%)
DIS   112.95 (+0.01%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.37 (-0.22%)
QQQ   423.32 (-0.59%)
AAPL   166.93 (-0.64%)
MSFT   405.46 (-1.55%)
META   502.30 (+1.65%)
GOOGL   156.26 (+0.51%)
AMZN   179.19 (-1.15%)
TSLA   150.47 (-3.20%)
NVDA   845.58 (+0.62%)
AMD   154.32 (+0.19%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.23 (+0.68%)
F   12.03 (-0.08%)
MU   112.61 (-3.20%)
GE   153.77 (-1.22%)
CGC   8.15 (+25.58%)
DIS   112.95 (+0.01%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.37 (-0.22%)
QQQ   423.32 (-0.59%)
AAPL   166.93 (-0.64%)
MSFT   405.46 (-1.55%)
META   502.30 (+1.65%)
GOOGL   156.26 (+0.51%)
AMZN   179.19 (-1.15%)
TSLA   150.47 (-3.20%)
NVDA   845.58 (+0.62%)
AMD   154.32 (+0.19%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.23 (+0.68%)
F   12.03 (-0.08%)
MU   112.61 (-3.20%)
GE   153.77 (-1.22%)
CGC   8.15 (+25.58%)
DIS   112.95 (+0.01%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.37 (-0.22%)
Free Trial

Sabra Health Care REIT (SBRA) Stock Forecast & Price Target

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free sbra Stock Alerts
$13.37
-0.09 (-0.67%)
(As of 02:46 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Sabra Health Care REIT Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 10 Analyst Ratings

Analysts' Consensus Price Target

$15.54
16.24% Upside
High Forecast$21.00
Average Forecast$15.54
Low Forecast$12.50
TypeCurrent Forecast
4/19/23 to 4/18/24		1 Month Ago
3/20/23 to 3/19/24		3 Months Ago
1/19/23 to 1/19/24		1 Year Ago
4/19/22 to 4/19/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
2 Buy rating(s)
Hold
4 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$15.54$15.35$14.79$13.30
Predicted Upside16.24% Upside14.83% Upside10.90% Upside4.93% Upside
Get Sabra Health Care REIT Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SBRA and its competitors with MarketBeat's FREE daily newsletter.

SBRA Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SBRA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Sabra Health Care REIT Stock vs. The Competition

TypeSabra Health Care REITFinance CompaniesS&P 500
Consensus Rating Score
2.60
2.43
2.49
Consensus RatingModerate BuyHoldHold
Predicted Upside15.47% Upside80.51% Upside12.25% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/29/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOutperform$17.00+22.92%
1/30/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageBuy$21.00+55.79%
1/3/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy$15.00 ➝ $17.00+19.63%
11/7/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy$14.00 ➝ $16.00+14.94%
10/17/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOutperform ➝ Market Perform$16.00+9.89%
10/16/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeUnderweight ➝ Equal Weight$13.00 ➝ $15.00+5.41%
10/10/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeNeutral ➝ Buy$14.00 ➝ $16.00+14.20%
9/29/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$13.00 ➝ $15.00+7.14%
9/20/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeHold ➝ Buy$11.00 ➝ $15.00+12.28%
7/27/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageHold$13.00-0.99%
7/14/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetNeutral$11.00 ➝ $12.50-1.50%
4/25/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$15.00 ➝ $13.00+18.18%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 03:03 PM ET.

SBRA Price Target - Frequently Asked Questions

What is Sabra Health Care REIT's consensus rating and price target?

According to the issued ratings of 10 analysts in the last year, the consensus rating for Sabra Health Care REIT stock is Moderate Buy based on the current 4 hold ratings and 6 buy ratings for SBRA. The average twelve-month price prediction for Sabra Health Care REIT is $15.54 with a high price target of $21.00 and a low price target of $12.50. Learn more on SBRA's analyst rating history.

Do Wall Street analysts like Sabra Health Care REIT more than its competitors?

Analysts like Sabra Health Care REIT more than other Finance companies. The consensus rating for Sabra Health Care REIT is Moderate Buy while the average consensus rating for finance companies is Hold. Learn more on how SBRA compares to other companies.

Does Sabra Health Care REIT's stock price have much upside?

According to analysts, Sabra Health Care REIT's stock has a predicted upside of 14.03% based on their 12-month stock forecasts.

What analysts cover Sabra Health Care REIT?

Sabra Health Care REIT has been rated by Deutsche Bank Aktiengesellschaft, and Wedbush in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:SBRA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
GoldenCrest Metals
Next President (Not Trump. Not Biden.)
The Freeport Society
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
The only accurate crypto trading system I know …
Weiss Ratings